Aurora Cannabis Inc. closed 54.01% short of its 52-week high of $9.35, which the company achieved on April 30th.

Aurora Cannabis Inc. closed 52.83% short of its 52-week high of $9.35, which the company reached on April 30th.

Aurora Cannabis produces and sells a variety of cannabis products, including dried cannabis, oils, capsules, and topical treatments, primarily for medical patients. It also manufactures and sells ...

Canada & Portugal lead supply. Javier Hasse This Week In Cannabis: DeSantis' Anti-Weed Push, NY's Drug Decriminalization, Aurora's Record Earnings, Tilray And More Global News Cannabis news ...

The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year ...

Analysts raised concerns about potential pricing impacts from increased competition in global medical cannabis markets. Martin emphasized Aurora’s competitive advantages, including regulatory ...

Aurora Cannabis (TSX:ACB) is expanding its pastille offerings in Australia, marking a significant step in the company’s move to diversify its range of medical cannabis products ・This expansion aims to ...

Reports Total Net Revenue of $88.2 Million, up 37% YoY, Including Record Net Revenue of $68.1 Million in Global Medical Cannabis, up 51% YoY. Aurora Cannabis Inc. shares T.ACB are trading up $2.00 at ...

Greetings and welcome to the Aurora Cannabis Inc. Third Quarter 2025 Results Conference Call. All participants will be in a listen-only mode and a question-and-answer session will follow the ...

Has Aurora Cannabis Inc. (ACB) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer ...